ADALIMUMAB

UNII:	FYS6T7F842
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	ADALIMUMAB
GSRS Full Record:	FYS6T7F842 i

331731-18-1
ABP-501
ABRILADA
ADALIMUMAB (AbbVie)
ADALIMUMAB (GENETICAL RECOMBINATION)
ADALIMUMAB (GENETICAL RECOMBINATION) [JAN]
ADALIMUMAB (HUMIRA)
ADALIMUMAB BETA
ADALIMUMAB BIOSIMILAR (ALVOTECH)
ADALIMUMAB BIOSIMILAR (AMGEN)
ADALIMUMAB BIOSIMILAR (AVT02)
ADALIMUMAB BIOSIMILAR (Boehringer Ingelheim)
ADALIMUMAB BIOSIMILAR (CELLTRION)
ADALIMUMAB BIOSIMILAR (CT-P17)
ADALIMUMAB BIOSIMILAR (FKB-327)
ADALIMUMAB BIOSIMILAR (FUJIFILM KYOWA KIRIN BIOLOGICS)
ADALIMUMAB BIOSIMILAR (MSB11022)
ADALIMUMAB BIOSIMILAR (MYLAN)
ADALIMUMAB BIOSIMILAR (PF-06410293)
ADALIMUMAB BIOSIMILAR (PFIZER)
ADALIMUMAB BIOSIMILAR (SAMSUNG BIOEPIS)
ADALIMUMAB BIOSIMILAR (SANDOZ)
ADALIMUMAB BIOSIMILAR (ZRC-3197)
ADALIMUMAB BIOSIMILAR (ZRC-3197)
ADALIMUMAB [EMA EPAR]
ADALIMUMAB [HSDB]
ADALIMUMAB [JAN]
ADALIMUMAB [MART.]
ADALIMUMAB [MI]
ADALIMUMAB [PURPLE BOOK CDER]
ADALIMUMAB [USAN]
ADALIMUMAB [VANDF]
ADALIMUMAB, LICENSE HOLDER UNSPECIFIED
ADALIMUMAB-AATY
ADALIMUMAB-ADAZ
ADALIMUMAB-ADAZ [PURPLE BOOK CDER]
ADALIMUMAB-ADBM
ADALIMUMAB-ADBM [PURPLE BOOK CDER]
ADALIMUMAB-AFZB
ADALIMUMAB-ATTO
ADALIMUMAB-ATTO [PURPLE BOOK CDER]
ADALIMUMAB-BWWD
ADALIMUMAB-FKJP
AMJEVITA
AVT-02
AVT02
Adalimumab [WHO-DD]
Adalimumab aacf [WHO-DD]
Adalimumab aaty [WHO-DD]
Adalimumab adaz [WHO-DD]
Adalimumab adbm [WHO-DD]
Adalimumab afzb [WHO-DD]
Adalimumab atto [WHO-DD]
Adalimumab bwwd [WHO-DD]
Adalimumab fkjp [WHO-DD]
Adalimumab ryvk [WHO-DD]
Adalimumab-AACF
Adalimumab-RYVK
Amsparity
BI 695501 [WHO-DD]
BI-695501
BI695501
CT P17 [WHO-DD]
CT-P17
CTP17
CYLTEZO
D2E7
D3E7
EXEMPTIA
EXEMPTIA
FKB-327
GP-2017
GP2017
HADLIMA
HULIO
HUMIRA
HYRIMOZ
IDACIO
IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR NECROSIS FACTOR) (HUMAN MONOCLONAL D2E7 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL D2E7 LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR NECROSIS FACTOR) (HUMAN MONOCLONAL D2E7 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL D2E7 LIGHT CHAIN, DIMER
LU-200134
LU200134
MSB-11022
MSB11022
PF-06410293
SB-5
SB5
SIMLANDI
TRUDEXA
YUFLYMA
ZRC-3197
ZRC-3197
ZRC3197
ZRC3197
adalimumab [INN]
adalimumab beta [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ADALIMUMAB

Synonyms and Mappings

Resources